nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Digestion impaired—Chlorambucil—testicular cancer	0.0285	0.0285	CcSEcCtD
Betahistine—Dermatitis atopic—Chlorambucil—testicular cancer	0.0257	0.0257	CcSEcCtD
Betahistine—Ventricular extrasystoles—Ifosfamide—testicular cancer	0.014	0.014	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.0106	0.0106	CcSEcCtD
Betahistine—Hallucination—Chlorambucil—testicular cancer	0.00952	0.00952	CcSEcCtD
Betahistine—Bronchospasm—Bleomycin—testicular cancer	0.0091	0.0091	CcSEcCtD
Betahistine—Erythema multiforme—Chlorambucil—testicular cancer	0.00905	0.00905	CcSEcCtD
Betahistine—Bronchospasm—Ifosfamide—testicular cancer	0.00778	0.00778	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00763	0.00763	CcSEcCtD
Betahistine—Angioedema—Chlorambucil—testicular cancer	0.00761	0.00761	CcSEcCtD
Betahistine—Dermatitis atopic—Epirubicin—testicular cancer	0.00754	0.00754	CcSEcCtD
Betahistine—Convulsion—Chlorambucil—testicular cancer	0.00722	0.00722	CcSEcCtD
Betahistine—Orthostatic hypotension—Cisplatin—testicular cancer	0.0072	0.0072	CcSEcCtD
Betahistine—Ill-defined disorder—Vinblastine—testicular cancer	0.00708	0.00708	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00699	0.00699	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—testicular cancer	0.00698	0.00698	CcSEcCtD
Betahistine—Malaise—Vinblastine—testicular cancer	0.00688	0.00688	CcSEcCtD
Betahistine—Confusional state—Chlorambucil—testicular cancer	0.00685	0.00685	CcSEcCtD
Betahistine—Convulsion—Vinblastine—testicular cancer	0.00661	0.00661	CcSEcCtD
Betahistine—Erythema multiforme—Dactinomycin—testicular cancer	0.00653	0.00653	CcSEcCtD
Betahistine—Discomfort—Vinblastine—testicular cancer	0.00642	0.00642	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—testicular cancer	0.00635	0.00635	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—testicular cancer	0.00635	0.00635	CcSEcCtD
Betahistine—Hallucination—Ifosfamide—testicular cancer	0.0063	0.0063	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—testicular cancer	0.00618	0.00618	CcSEcCtD
Betahistine—Bronchospasm—Etoposide—testicular cancer	0.00614	0.00614	CcSEcCtD
Betahistine—Erythema multiforme—Ifosfamide—testicular cancer	0.00598	0.00598	CcSEcCtD
Betahistine—Dyspepsia—Chlorambucil—testicular cancer	0.00598	0.00598	CcSEcCtD
Betahistine—Ill-defined disorder—Bleomycin—testicular cancer	0.00598	0.00598	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—testicular cancer	0.00588	0.00588	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—testicular cancer	0.00588	0.00588	CcSEcCtD
Betahistine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00587	0.00587	CcSEcCtD
Betahistine—Fatigue—Chlorambucil—testicular cancer	0.00586	0.00586	CcSEcCtD
Betahistine—Malaise—Bleomycin—testicular cancer	0.00581	0.00581	CcSEcCtD
Betahistine—Immune system disorder—Ifosfamide—testicular cancer	0.00572	0.00572	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.00572	0.00572	CcSEcCtD
Betahistine—Feeling abnormal—Chlorambucil—testicular cancer	0.0056	0.0056	CcSEcCtD
Betahistine—Ill-defined disorder—Dactinomycin—testicular cancer	0.00558	0.00558	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00552	0.00552	CcSEcCtD
Betahistine—Discomfort—Bleomycin—testicular cancer	0.00542	0.00542	CcSEcCtD
Betahistine—Malaise—Dactinomycin—testicular cancer	0.00542	0.00542	CcSEcCtD
Betahistine—Urticaria—Chlorambucil—testicular cancer	0.0054	0.0054	CcSEcCtD
Betahistine—Confusional state—Bleomycin—testicular cancer	0.00531	0.00531	CcSEcCtD
Betahistine—Anaphylactic shock—Bleomycin—testicular cancer	0.00526	0.00526	CcSEcCtD
Betahistine—Feeling abnormal—Vinblastine—testicular cancer	0.00513	0.00513	CcSEcCtD
Betahistine—Ill-defined disorder—Ifosfamide—testicular cancer	0.00511	0.00511	CcSEcCtD
Betahistine—Discomfort—Dactinomycin—testicular cancer	0.00506	0.00506	CcSEcCtD
Betahistine—Angioedema—Ifosfamide—testicular cancer	0.00503	0.00503	CcSEcCtD
Betahistine—Hypersensitivity—Chlorambucil—testicular cancer	0.00501	0.00501	CcSEcCtD
Betahistine—Malaise—Ifosfamide—testicular cancer	0.00497	0.00497	CcSEcCtD
Betahistine—Immune system disorder—Cisplatin—testicular cancer	0.00493	0.00493	CcSEcCtD
Betahistine—Asthenia—Chlorambucil—testicular cancer	0.00488	0.00488	CcSEcCtD
Betahistine—Pruritus—Chlorambucil—testicular cancer	0.00481	0.00481	CcSEcCtD
Betahistine—Convulsion—Ifosfamide—testicular cancer	0.00477	0.00477	CcSEcCtD
Betahistine—Erythema multiforme—Etoposide—testicular cancer	0.00473	0.00473	CcSEcCtD
Betahistine—Dyspnoea—Bleomycin—testicular cancer	0.00469	0.00469	CcSEcCtD
Betahistine—Flatulence—Cisplatin—testicular cancer	0.00468	0.00468	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00466	0.00466	CcSEcCtD
Betahistine—Diarrhoea—Chlorambucil—testicular cancer	0.00465	0.00465	CcSEcCtD
Betahistine—Discomfort—Ifosfamide—testicular cancer	0.00463	0.00463	CcSEcCtD
Betahistine—Hypersensitivity—Vinblastine—testicular cancer	0.00459	0.00459	CcSEcCtD
Betahistine—Confusional state—Ifosfamide—testicular cancer	0.00453	0.00453	CcSEcCtD
Betahistine—Immune system disorder—Etoposide—testicular cancer	0.00452	0.00452	CcSEcCtD
Betahistine—Anaphylactic shock—Ifosfamide—testicular cancer	0.0045	0.0045	CcSEcCtD
Betahistine—Asthenia—Vinblastine—testicular cancer	0.00447	0.00447	CcSEcCtD
Betahistine—Nervous system disorder—Ifosfamide—testicular cancer	0.00441	0.00441	CcSEcCtD
Betahistine—Ill-defined disorder—Cisplatin—testicular cancer	0.00441	0.00441	CcSEcCtD
Betahistine—Skin disorder—Ifosfamide—testicular cancer	0.00437	0.00437	CcSEcCtD
Betahistine—Feeling abnormal—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Betahistine—Vomiting—Chlorambucil—testicular cancer	0.00432	0.00432	CcSEcCtD
Betahistine—Malaise—Cisplatin—testicular cancer	0.00428	0.00428	CcSEcCtD
Betahistine—Diarrhoea—Vinblastine—testicular cancer	0.00426	0.00426	CcSEcCtD
Betahistine—Fatigue—Dactinomycin—testicular cancer	0.00423	0.00423	CcSEcCtD
Betahistine—Urticaria—Bleomycin—testicular cancer	0.00418	0.00418	CcSEcCtD
Betahistine—Dizziness—Vinblastine—testicular cancer	0.00412	0.00412	CcSEcCtD
Betahistine—Convulsion—Cisplatin—testicular cancer	0.00412	0.00412	CcSEcCtD
Betahistine—Feeling abnormal—Dactinomycin—testicular cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Nausea—Chlorambucil—testicular cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Ill-defined disorder—Etoposide—testicular cancer	0.00404	0.00404	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00402	0.00402	CcSEcCtD
Betahistine—Dyspnoea—Ifosfamide—testicular cancer	0.00401	0.00401	CcSEcCtD
Betahistine—Somnolence—Ifosfamide—testicular cancer	0.004	0.004	CcSEcCtD
Betahistine—Discomfort—Cisplatin—testicular cancer	0.004	0.004	CcSEcCtD
Betahistine—Vomiting—Vinblastine—testicular cancer	0.00396	0.00396	CcSEcCtD
Betahistine—Malaise—Etoposide—testicular cancer	0.00392	0.00392	CcSEcCtD
Betahistine—Headache—Vinblastine—testicular cancer	0.0039	0.0039	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00388	0.00388	CcSEcCtD
Betahistine—Fatigue—Ifosfamide—testicular cancer	0.00388	0.00388	CcSEcCtD
Betahistine—Anaphylactic shock—Cisplatin—testicular cancer	0.00388	0.00388	CcSEcCtD
Betahistine—Hypersensitivity—Bleomycin—testicular cancer	0.00388	0.00388	CcSEcCtD
Betahistine—Nervous system disorder—Cisplatin—testicular cancer	0.0038	0.0038	CcSEcCtD
Betahistine—Tachycardia—Cisplatin—testicular cancer	0.00378	0.00378	CcSEcCtD
Betahistine—Asthenia—Bleomycin—testicular cancer	0.00377	0.00377	CcSEcCtD
Betahistine—Convulsion—Etoposide—testicular cancer	0.00377	0.00377	CcSEcCtD
Betahistine—Skin disorder—Cisplatin—testicular cancer	0.00377	0.00377	CcSEcCtD
Betahistine—Asthma—Methotrexate—testicular cancer	0.00374	0.00374	CcSEcCtD
Betahistine—Pruritus—Bleomycin—testicular cancer	0.00372	0.00372	CcSEcCtD
Betahistine—Feeling abnormal—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Betahistine—Nausea—Vinblastine—testicular cancer	0.0037	0.0037	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—testicular cancer	0.0037	0.0037	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—testicular cancer	0.0037	0.0037	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00368	0.00368	CcSEcCtD
Betahistine—Discomfort—Etoposide—testicular cancer	0.00366	0.00366	CcSEcCtD
Betahistine—Hypersensitivity—Dactinomycin—testicular cancer	0.00362	0.00362	CcSEcCtD
Betahistine—Confusional state—Etoposide—testicular cancer	0.00358	0.00358	CcSEcCtD
Betahistine—Urticaria—Ifosfamide—testicular cancer	0.00357	0.00357	CcSEcCtD
Betahistine—Anaphylactic shock—Etoposide—testicular cancer	0.00355	0.00355	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—testicular cancer	0.00352	0.00352	CcSEcCtD
Betahistine—Asthenia—Dactinomycin—testicular cancer	0.00352	0.00352	CcSEcCtD
Betahistine—Asthma—Epirubicin—testicular cancer	0.0035	0.0035	CcSEcCtD
Betahistine—Tachycardia—Etoposide—testicular cancer	0.00347	0.00347	CcSEcCtD
Betahistine—Dyspnoea—Cisplatin—testicular cancer	0.00346	0.00346	CcSEcCtD
Betahistine—Skin disorder—Etoposide—testicular cancer	0.00345	0.00345	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00342	0.00342	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00342	0.00342	CcSEcCtD
Betahistine—Diarrhoea—Dactinomycin—testicular cancer	0.00336	0.00336	CcSEcCtD
Betahistine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00335	0.00335	CcSEcCtD
Betahistine—Vomiting—Bleomycin—testicular cancer	0.00335	0.00335	CcSEcCtD
Betahistine—Rash—Bleomycin—testicular cancer	0.00332	0.00332	CcSEcCtD
Betahistine—Dermatitis—Bleomycin—testicular cancer	0.00331	0.00331	CcSEcCtD
Betahistine—Hypersensitivity—Ifosfamide—testicular cancer	0.00331	0.00331	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00331	0.00331	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Betahistine—Asthma—Doxorubicin—testicular cancer	0.00324	0.00324	CcSEcCtD
Betahistine—Asthenia—Ifosfamide—testicular cancer	0.00323	0.00323	CcSEcCtD
Betahistine—Feeling abnormal—Cisplatin—testicular cancer	0.00319	0.00319	CcSEcCtD
Betahistine—Pruritus—Ifosfamide—testicular cancer	0.00318	0.00318	CcSEcCtD
Betahistine—Dyspnoea—Etoposide—testicular cancer	0.00317	0.00317	CcSEcCtD
Betahistine—Somnolence—Etoposide—testicular cancer	0.00316	0.00316	CcSEcCtD
Betahistine—Nausea—Bleomycin—testicular cancer	0.00313	0.00313	CcSEcCtD
Betahistine—Vomiting—Dactinomycin—testicular cancer	0.00312	0.00312	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00309	0.00309	CcSEcCtD
Betahistine—Rash—Dactinomycin—testicular cancer	0.00309	0.00309	CcSEcCtD
Betahistine—Diarrhoea—Ifosfamide—testicular cancer	0.00308	0.00308	CcSEcCtD
Betahistine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00307	0.00307	CcSEcCtD
Betahistine—Fatigue—Etoposide—testicular cancer	0.00306	0.00306	CcSEcCtD
Betahistine—Dizziness—Ifosfamide—testicular cancer	0.00297	0.00297	CcSEcCtD
Betahistine—Feeling abnormal—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Betahistine—Nausea—Dactinomycin—testicular cancer	0.00291	0.00291	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Betahistine—Vomiting—Ifosfamide—testicular cancer	0.00286	0.00286	CcSEcCtD
Betahistine—Hypersensitivity—Cisplatin—testicular cancer	0.00286	0.00286	CcSEcCtD
Betahistine—Rash—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Betahistine—Dermatitis—Ifosfamide—testicular cancer	0.00283	0.00283	CcSEcCtD
Betahistine—Erythema multiforme—Methotrexate—testicular cancer	0.00283	0.00283	CcSEcCtD
Betahistine—Urticaria—Etoposide—testicular cancer	0.00282	0.00282	CcSEcCtD
Betahistine—Asthenia—Cisplatin—testicular cancer	0.00278	0.00278	CcSEcCtD
Betahistine—Immune system disorder—Methotrexate—testicular cancer	0.0027	0.0027	CcSEcCtD
Betahistine—Nausea—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Betahistine—Diarrhoea—Cisplatin—testicular cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—testicular cancer	0.00265	0.00265	CcSEcCtD
Betahistine—Hypersensitivity—Etoposide—testicular cancer	0.00262	0.00262	CcSEcCtD
Betahistine—Asthenia—Etoposide—testicular cancer	0.00255	0.00255	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—testicular cancer	0.00253	0.00253	CcSEcCtD
Betahistine—Pruritus—Etoposide—testicular cancer	0.00251	0.00251	CcSEcCtD
Betahistine—Vomiting—Cisplatin—testicular cancer	0.00246	0.00246	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Betahistine—Rash—Cisplatin—testicular cancer	0.00244	0.00244	CcSEcCtD
Betahistine—Dermatitis—Cisplatin—testicular cancer	0.00244	0.00244	CcSEcCtD
Betahistine—Diarrhoea—Etoposide—testicular cancer	0.00243	0.00243	CcSEcCtD
Betahistine—Ill-defined disorder—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Betahistine—Flatulence—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Betahistine—Malaise—Methotrexate—testicular cancer	0.00235	0.00235	CcSEcCtD
Betahistine—Dizziness—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Betahistine—Nausea—Cisplatin—testicular cancer	0.0023	0.0023	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Convulsion—Methotrexate—testicular cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Vomiting—Etoposide—testicular cancer	0.00226	0.00226	CcSEcCtD
Betahistine—Rash—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Betahistine—Dermatitis—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Betahistine—Headache—Etoposide—testicular cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.0022	0.0022	CcSEcCtD
Betahistine—Malaise—Epirubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Betahistine—Discomfort—Methotrexate—testicular cancer	0.00219	0.00219	CcSEcCtD
Betahistine—Confusional state—Methotrexate—testicular cancer	0.00214	0.00214	CcSEcCtD
Betahistine—Anaphylactic shock—Methotrexate—testicular cancer	0.00213	0.00213	CcSEcCtD
Betahistine—Convulsion—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Betahistine—Nausea—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Nervous system disorder—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Betahistine—Skin disorder—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Betahistine—Discomfort—Epirubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Betahistine—Malaise—Doxorubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Betahistine—Confusional state—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00191	0.00191	CcSEcCtD
Betahistine—Discomfort—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Dyspnoea—Methotrexate—testicular cancer	0.0019	0.0019	CcSEcCtD
Betahistine—Somnolence—Methotrexate—testicular cancer	0.00189	0.00189	CcSEcCtD
Betahistine—Dyspepsia—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Betahistine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Betahistine—Fatigue—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Betahistine—Nervous system disorder—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Betahistine—Tachycardia—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Betahistine—Dyspnoea—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Betahistine—Somnolence—Epirubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Betahistine—Feeling abnormal—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Betahistine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Fatigue—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Betahistine—Urticaria—Methotrexate—testicular cancer	0.00169	0.00169	CcSEcCtD
Betahistine—Dyspnoea—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Somnolence—Doxorubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Betahistine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Betahistine—Urticaria—Epirubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Betahistine—Hypersensitivity—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Betahistine—Asthenia—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Betahistine—Feeling abnormal—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Betahistine—Pruritus—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Betahistine—Hypersensitivity—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Betahistine—Diarrhoea—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Betahistine—Asthenia—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Betahistine—Pruritus—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Betahistine—Dizziness—Methotrexate—testicular cancer	0.00141	0.00141	CcSEcCtD
Betahistine—Diarrhoea—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Betahistine—Hypersensitivity—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Betahistine—Vomiting—Methotrexate—testicular cancer	0.00135	0.00135	CcSEcCtD
Betahistine—Rash—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Betahistine—Dermatitis—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Betahistine—Headache—Methotrexate—testicular cancer	0.00133	0.00133	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Betahistine—Dizziness—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Betahistine—Vomiting—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Betahistine—Nausea—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Rash—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Betahistine—Headache—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Betahistine—Dizziness—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Betahistine—Nausea—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Betahistine—Vomiting—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Betahistine—Rash—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Betahistine—Headache—Doxorubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Betahistine—Nausea—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
